Features of the current course and treatment of pulmonary sarcoidosis (case from clinical practice)
-
Published:2024-06-28
Issue:2
Volume:28
Page:259-264
-
ISSN:2522-9354
-
Container-title:Reports of Vinnytsia National Medical University
-
language:
-
Short-container-title:Rep. of Vinnytsia Nation. Med. Univ.
Author:
Nezgoda О. P.ORCID, Holubets А. V.ORCID, Chernachuk А. P.ORCID, Plykanchuk О. V.ORCID
Abstract
Annotation. The key issues with respect to pulmonary sarcoidosis have been raised in the article. Sarcoidosis is a systemic immune mediated disease characterised by granulomas. In recent years, both abroad and within Ukraine, there has been a rapid increase in prevalence, occurrence and mortality due to the said pathology. In Ukraine, the morbidity rate of pulmonary sarcoidosis varies from 1,1 to 2,8 depending on a region. A medical case of pulmonary sarcoidosis, including detailed review of the course and relapses of the nosological entity, dynamics of treatment of the disease and complications of hormone therapy, has been demonstrated. There have been presented the latest update literature data related to the clinical features, up-to-date diagnostic techniques and treatment of the nosological entity.
Publisher
Vinnytsia National Pyrogov Memorial Medical University
Reference37 articles.
1. Arkema, E. V., & Cozier, Y. C. (2018). Epidemiology of sarcoidosis: current findings and future directions. Therapeutic Advances in Chronic Disease, 204062231879019. doi:10.1177/2040622318790197 2. Baughman, R. P., Field, S., Costabel, U., Crystal, R. G., Culver, D. A., Drent, M., … & Wolff, G. (2016). Sarcoidosis in America. Analysis Based on Health Care Use. Annals of the American Thoracic Society, 13(8), 1244-1252. doi:10.1513/annalsats.201511-760oc 3. Baughman, R. P., Judson, M. A., Culver, D. A., Birring, S. S., Parambil, J., Zeigler, J., & Lower, E. E. (2021) Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial. Sarcoidosis Vasc Diffuse Lung Dis., 38(3), e2021035. doi: 10.36141/svdld.v38i3.11684 4. Belperio, J. A., Fishbein, M. C., Abtin, F., Channick, J., Balasubramanian, S. A., & Lynch 3rd, J. P. (2023). Pulmonary sarcoidosis: A comprehensive review: Past to present. J Autoimmun, 103107. doi: 10.1016/j.jaut.2023.103107 5. Belperio, J. A., Shaikh, F., Abtin, F. G., Fishbein, M. C., Weigt, S. S., Saggar, R., & Lynch 3rd, J. P. (2022). Diagnosis and treatment of pulmonary sarcoidosis: a review. JAMA, 327(9), 856-867. doi:10.1001/jama. 2022.1570
|
|